PDF(Pubmed)
Abstract：
UNASSIGNED: Compass Rose™, a case management tool developed by Epic®, was designed to track various patient coordination tasks, outreaches, and outcomes. This report describes the implementation of Compass Rose™ within an internal health-system specialty pharmacy (HSSP) and changes in care coordination metrics before and after implementation. To the best of our knowledge, this is the first study of its kind to discuss the implementation of Compass Rose™.
UNASSIGNED: The goals of this study were to describe the implementation process of Compass Rose™ at an internal HSSP and compare staff satisfaction before and after Compass Rose™ as the primary outcome.
UNASSIGNED: This was an Institutional Review Board exempt, retrospective cohort study conducted between June 2022 to December 2022 that assessed staff satisfaction, refill documentation time, prescription turnaround time, and patient satisfaction pre- and post- Compass Rose™ implementation through survey administration, observed time studies, and internal data reports. The process of Compass Rose™ implementation was also described and discussed.
UNASSIGNED: 24 specialty pharmacy staff members participated in the Compass Rose™ implementation survey. No statistically significant differences were observed in either staff satisfaction (3.96 ± 0.95 versus 3.70 ± 0.69, p = 0.29) or predicted versus actual challenge of implementation (3.67 ± 1.17 versus 3.09 ± 0.96, p = 0.064). There was no significant difference in refill documentation time pre- versus post- Compass Rose™ implementation (4.22 ± 3.15 minutes versus 4.10 ± 2.36 minutes, p = 0.82); however, there was a statistically significant increase in prescription turnaround time post implementation (2.59 ± 2.85 days versus 2.69 ± 2.35 days, p = 0.002).
UNASSIGNED: Compass Rose™ implementation had no significant impact on staff satisfaction, patient satisfaction, or overall refill documentation time. Prescription turnaround time increased, which could be due to significant workflow changes with Compass Rose™ or several other contributing factors such as increased prescription volume and training new staff during this period.Benefits of Compass Rose™ included standardization of workflow, ability to quantify staff performance and clinical impact, and increased transparency regarding care provided by the specialty pharmacy team.
UNASSIGNED: The goals of this study were to describe the implementation process of Compass Rose™ at an internal HSSP and compare staff satisfaction before and after Compass Rose™ as the primary outcome.
UNASSIGNED: This was an Institutional Review Board exempt, retrospective cohort study conducted between June 2022 to December 2022 that assessed staff satisfaction, refill documentation time, prescription turnaround time, and patient satisfaction pre- and post- Compass Rose™ implementation through survey administration, observed time studies, and internal data reports. The process of Compass Rose™ implementation was also described and discussed.
UNASSIGNED: 24 specialty pharmacy staff members participated in the Compass Rose™ implementation survey. No statistically significant differences were observed in either staff satisfaction (3.96 ± 0.95 versus 3.70 ± 0.69, p = 0.29) or predicted versus actual challenge of implementation (3.67 ± 1.17 versus 3.09 ± 0.96, p = 0.064). There was no significant difference in refill documentation time pre- versus post- Compass Rose™ implementation (4.22 ± 3.15 minutes versus 4.10 ± 2.36 minutes, p = 0.82); however, there was a statistically significant increase in prescription turnaround time post implementation (2.59 ± 2.85 days versus 2.69 ± 2.35 days, p = 0.002).
UNASSIGNED: Compass Rose™ implementation had no significant impact on staff satisfaction, patient satisfaction, or overall refill documentation time. Prescription turnaround time increased, which could be due to significant workflow changes with Compass Rose™ or several other contributing factors such as increased prescription volume and training new staff during this period.Benefits of Compass Rose™ included standardization of workflow, ability to quantify staff performance and clinical impact, and increased transparency regarding care provided by the specialty pharmacy team.
摘要：
■罗盘玫瑰™，Epic®开发的案例管理工具，旨在跟踪各种患者协调任务，外展,和结果。本报告介绍了CompassRose™在内部卫生系统专业药房（HSSP）中的实施以及实施前后护理协调指标的变化。据我们所知,这是第一个讨论CompassRose™实施的同类研究。
■本研究的目标是描述CompassRose™在内部HSSP的实施过程，并比较CompassRose™之前和之后的员工满意度作为主要结果。
■这是一个机构审查委员会豁免，2022年6月至2022年12月进行的回顾性队列研究，评估员工满意度，补充文档时间，处方周转时间，以及通过调查管理实施罗盘Rose™前后的患者满意度，观察时间研究，和内部数据报告。还描述和讨论了CompassRose™实现的过程。
■24名专业药房工作人员参加了CompassRose™实施调查。在员工满意度（3.96±0.95对3.70±0.69，p=0.29）或预测与实际实施挑战（3.67±1.17对3.09±0.96，p=0.064）方面均未观察到统计学上的显着差异。实施罗盘Rose™前后的再填充文档时间没有显着差异（4.22±3.15分钟对4.10±2.36分钟，p=0.82)；然而，处方实施后的周转时间有统计学上的显着增加（2.59±2.85天对2.69±2.35天，p=0.002)。
■CompassRose™的实施对员工满意度没有重大影响，患者满意度,或总补充文档时间。处方周转时间增加，这可能是由于CompassRose™的重大工作流程更改或其他几个促成因素，例如在此期间处方量增加和培训新员工。CompassRose™的优点包括工作流程的标准化，量化员工绩效和临床影响的能力，并提高了由专业药房团队提供的护理的透明度。
■本研究的目标是描述CompassRose™在内部HSSP的实施过程，并比较CompassRose™之前和之后的员工满意度作为主要结果。
■这是一个机构审查委员会豁免，2022年6月至2022年12月进行的回顾性队列研究，评估员工满意度，补充文档时间，处方周转时间，以及通过调查管理实施罗盘Rose™前后的患者满意度，观察时间研究，和内部数据报告。还描述和讨论了CompassRose™实现的过程。
■24名专业药房工作人员参加了CompassRose™实施调查。在员工满意度（3.96±0.95对3.70±0.69，p=0.29）或预测与实际实施挑战（3.67±1.17对3.09±0.96，p=0.064）方面均未观察到统计学上的显着差异。实施罗盘Rose™前后的再填充文档时间没有显着差异（4.22±3.15分钟对4.10±2.36分钟，p=0.82)；然而，处方实施后的周转时间有统计学上的显着增加（2.59±2.85天对2.69±2.35天，p=0.002)。
■CompassRose™的实施对员工满意度没有重大影响，患者满意度,或总补充文档时间。处方周转时间增加，这可能是由于CompassRose™的重大工作流程更改或其他几个促成因素，例如在此期间处方量增加和培训新员工。CompassRose™的优点包括工作流程的标准化，量化员工绩效和临床影响的能力，并提高了由专业药房团队提供的护理的透明度。
